BEONE
Live / Allowed — Notice of allowance issued (as of 10 Jun 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Sept 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98746778
- Mark type
- Stylized text
- Filed
- 12 Sept 2024
- Published for opposition
- 15 Apr 2025
- Attorney of record
- Kristen Ruisi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
- Class 040 — Treatment of materials: Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
- Class 042 — Scientific and technological services: Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; scientific research in the nature of conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design
- Class 044 — Medical, beauty and agricultural services: Telemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advice, namely, pharmaceutical advice
Owner
- BEONE MEDICINES I GMBH, BASEL, CH
- BeiGene Switzerland GMBH, Basel, CH
- BeiGene Switzerland GMBH, Basel, CH
Prosecution history
- 04 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 10 Jul 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Jul 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 10 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Apr 2025 — PUBLISHED FOR OPPOSITION
- 09 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Mar 2025 — EXAMINER'S AMENDMENT ENTERED
- 17 Mar 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 17 Mar 2025 — EXAMINERS AMENDMENT E-MAILED
- 17 Mar 2025 — EXAMINERS AMENDMENT -WRITTEN
- 12 Mar 2025 — ASSIGNED TO EXAMINER
- 24 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 Sept 2024 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED